search
Back to results

Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn (PGRIV)

Primary Purpose

Type2 Diabetes Mellitus, Metabolic Syndrome

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Glucola
Whole pea meal
Pea flour meal
Whole lentils
Lentil flour
Sponsored by
Iowa State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Type2 Diabetes Mellitus focused on measuring Glycemic response, Glucose, Type 2 diabetes, Legumes, Metabolic Syndrome

Eligibility Criteria

24 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 24-70 years
  • BMI between 22-40
  • Medical diagnosis of type 2 diabetes
  • HbA1C <10%)
  • OR have 3+ indicators of metabolic syndrome (high triglycerides, low HDL-cholesterol, high blood pressure) plus prediabetes HbA1c.

Exclusion Criteria:

  • Uncontrolled hypertension or other health issues, e.g., gastrointestinal disease
  • Weight changes of >10% of participants body weight within a 6 month period
  • Pregnant or breastfeeding
  • Allergy to peas, lentils, tomatoes, gluten, or latex
  • HgbA1c level of >10% at screening
  • Unwillingness or inability to follow study protocol.

Sites / Locations

  • Iowa State University, Food Science and Human Nutrition Department

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Experimental

Arm Label

Control - Glucola

Whole peas

Pea Flour

Whole lentils

Lentil flour

Arm Description

Glucola control beverage

Whole cooked peas in a 50 gram carbohydrate meal dose

Pea flour in a 50 gram carbohydrate meal dose

Whole cooked lentils in a 50 gram carbohydrate meal dose

Lentil flour in a 50 gram carbohydrate meal dose

Outcomes

Primary Outcome Measures

Change in baseline blood glucose over 3 hours (glycemic response)
Venous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at Quest Diagnostics.

Secondary Outcome Measures

Change in gastrointestinal symptoms
Gastrointestinal concerns and changes were noted on a descriptive questionnaire
Change in satiety sensation
Satiety level measured using a visual analog scale (0-100) every 30 minutes postprandially. A higher score indicates greater satiety.

Full Information

First Posted
January 16, 2020
Last Updated
November 23, 2021
Sponsor
Iowa State University
Collaborators
USA Dry Pea & Lentil Council
search

1. Study Identification

Unique Protocol Identification Number
NCT05145998
Brief Title
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
Acronym
PGRIV
Official Title
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes Mellitus or Metabolic Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
May 23, 2018 (Actual)
Primary Completion Date
February 29, 2020 (Actual)
Study Completion Date
February 29, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Iowa State University
Collaborators
USA Dry Pea & Lentil Council

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine glycemic response of four different meals containing either whole green peas, whole lentils, powdered green peas, or powdered lentils in comparison to Glucola. Participants are adults with type 2 diabetes mellitus or metabolic syndrome.
Detailed Description
The 5 test treatments (Glucola, whole green peas, green pea flour, whole lentils, and lentil flour) will be administered randomly over five weeks. The test Participants will be required to consume the entire test treatment meal in 12 minutes while being observed. Venous blood samples will be collected for blood glucose and insulin levels at time 0 (fasting) and at 30, 60, 90, 120, and 180 minutes post-treatment (timing of the post-treatment blood draws started at time 0 [post-treatment], which is when the participant finishes consuming the treatment meal). During the first visit blood was drawn for a lipid panel and HbA1C values. Thyroid stimulating hormone (TSH) and complete blood count (CBC) values were analyzed during the second visit, and vitamin D levels analyzed during the final visit. Blood analysis was completed by a reputable biomarker diagnostics laboratory, Quest Diagnostics. Anthropometric measures such as weight, height, waist circumference, and blood pressure were collected at screening and at the start of each test day. Thirteen hours before testing, participants consumed a standardized frozen meal to reduce the potential variation in glycemic responses on test day due to varying pre-evening dietary intakes. This control meal was selected by each participant before the start of the study. Each participant was provided the same frozen meal every time, since the subjects serve as their own controls. The day before test day, participants completed a 24 hour food recall, satiety, and gastrointestinal questionnaires. The morning of each test day participants completed the International Physical Activity Questionnaire (IPAQ), satiety, and gastrointestinal questionnaires. Test meal and blood glucose results at the 5 test points were entered into SPSS statistical software (V. 25) for data cleaning and analysis. Physical activity and the 24 hour dietary recall data were used to classify individuals on activity and dietary quality. Satiety responses were compared against each of the 5 test meals for each participant as well as the gastrointestinal responses using SPSS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type2 Diabetes Mellitus, Metabolic Syndrome
Keywords
Glycemic response, Glucose, Type 2 diabetes, Legumes, Metabolic Syndrome

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
5 x 5 crossover study with 4 treatments and one control
Masking
None (Open Label)
Allocation
Randomized
Enrollment
19 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control - Glucola
Arm Type
Active Comparator
Arm Description
Glucola control beverage
Arm Title
Whole peas
Arm Type
Experimental
Arm Description
Whole cooked peas in a 50 gram carbohydrate meal dose
Arm Title
Pea Flour
Arm Type
Experimental
Arm Description
Pea flour in a 50 gram carbohydrate meal dose
Arm Title
Whole lentils
Arm Type
Experimental
Arm Description
Whole cooked lentils in a 50 gram carbohydrate meal dose
Arm Title
Lentil flour
Arm Type
Experimental
Arm Description
Lentil flour in a 50 gram carbohydrate meal dose
Intervention Type
Dietary Supplement
Intervention Name(s)
Glucola
Intervention Description
50 grams of Glucola sugar beverage
Intervention Type
Dietary Supplement
Intervention Name(s)
Whole pea meal
Intervention Description
Whole cooked peas with spaghetti sauce and a slice of bread.
Intervention Type
Dietary Supplement
Intervention Name(s)
Pea flour meal
Intervention Description
Pea flour with spaghetti sauce and a slice of bread.
Intervention Type
Dietary Supplement
Intervention Name(s)
Whole lentils
Intervention Description
Whole cooked lentils with spaghetti sauce and a slice of bread.
Intervention Type
Dietary Supplement
Intervention Name(s)
Lentil flour
Intervention Description
Lentil flour with spaghetti sauce and a slice of bread.
Primary Outcome Measure Information:
Title
Change in baseline blood glucose over 3 hours (glycemic response)
Description
Venous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at Quest Diagnostics.
Time Frame
Time 0 (fasting) then every 30 minutes for 3 hours
Secondary Outcome Measure Information:
Title
Change in gastrointestinal symptoms
Description
Gastrointestinal concerns and changes were noted on a descriptive questionnaire
Time Frame
3 hours postprandial, and 12 hours postprandial
Title
Change in satiety sensation
Description
Satiety level measured using a visual analog scale (0-100) every 30 minutes postprandially. A higher score indicates greater satiety.
Time Frame
Time 0 (fasting) then every 30 minutes for 3 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
24 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 24-70 years BMI between 22-40 Medical diagnosis of type 2 diabetes HbA1C <10%) OR have 3+ indicators of metabolic syndrome (high triglycerides, low HDL-cholesterol, high blood pressure) plus prediabetes HbA1c. Exclusion Criteria: Uncontrolled hypertension or other health issues, e.g., gastrointestinal disease Weight changes of >10% of participants body weight within a 6 month period Pregnant or breastfeeding Allergy to peas, lentils, tomatoes, gluten, or latex HgbA1c level of >10% at screening Unwillingness or inability to follow study protocol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Donna Winham, DrPH
Organizational Affiliation
Iowa State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Iowa State University, Food Science and Human Nutrition Department
City
Ames
State/Province
Iowa
ZIP/Postal Code
50011
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn

We'll reach out to this number within 24 hrs